Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04621825
Other study ID # PHMB Silicone 001
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date November 2, 2020
Est. completion date July 2024

Study information

Verified date January 2024
Source Advanced Medical Solutions Ltd.
Contact Rebecca Forder, BA (Hons)
Phone 01606 545677
Email Rebecca.forder@admedsol.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Post market surveillance study to confirm the safety and performance of Silicone Subcategory of PHMB Foam Dressings in Chronic and Acute Wounds.


Description:

The design of the study is an open label, multicentre, single arm trial with subjects with moderate to heavily exuding chronic and acute wounds consisting of pressure ulcers, leg ulcers, diabetic leg and foot ulcers, surgical wounds first degree superficial and partial thickness burns. The performance data from this study will support clinically meaningful rates of successful improvement in the signs and symptoms of infection, without refection during 6- week treatment and follow up period.


Recruitment information / eligibility

Status Recruiting
Enrollment 194
Est. completion date July 2024
Est. primary completion date May 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Have a pressure ulcer, leg ulcer, diabetic leg and foot ulcer, surgical wound, first degree superficial burns or partial thickness second degree burns that are infected following assessment of signs and symptoms of infection with moderate to heavy levels of exudate. - Have wounds at high risk of infection. - Males or females, age 18 years or above. - Subjects who are able to understand and give informed consent to take part in the study. Exclusion Criteria: - Subjects who are known to be non compliant with medical treatment. - Subjects who are known to be sensitive to any of the device components, known sensitivity to PHMB. - Subject is pregnant or actively breastfeeding. - Subject has any significant or unstable medical or psychiatric condition, that in the opinion of the investigator, would interfere with his/her ability to participate in the study. - Subject is currently in another clinical study. - Patients who have a current illness or condition, or who have had an illness in the last 30 days which in the opinion of the investigator may interfere with wound healing (e.g. carcinoma, connective tissue disease, autoimmune disease or alcohol or drug abuse). - Life expectancy of <6 months. - Maximum burn area of >20% total body area in adults.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
ActivHeal Silicone PHMB Foam Adhesive and Non Adhesive dressing.
Assigned interventions Subjects will undergo treatment of their chronic and acute wounds as indicated in instructions for use with ActivHeal Silicone PHMB Foam adhesive and Non Adhesive Foam dressings. Subjects will be evaluated as follows: Full Patient and wound assessment, Informed consent. Wound Assessment, application of dressings, (At each scheduled dressing change.) Wound Assessment, removal of dressings, (At each scheduled dressing change.) The patients will be evaluated at each dressing change over a four - six-week period (per AMS Product) or until the wound is healed to extent that the use of the ActivHeal Silicone PHMB Foam adhesive and Non Adhesive Foam dressings. is no longer indicated from the time that the patient has been recruited. The assessment of the presence and reduction of the signs and symptoms of Infection.

Locations

Country Name City State
South Africa Dr Thirumani Govender Bellville, Cape Town
South Africa Delft Day Hospital Premises Delft S. Cape Town
South Africa Brooklyn Chest Hospital Ysterplaat, Cape Town

Sponsors (2)

Lead Sponsor Collaborator
Advanced Medical Solutions Ltd. Imarc Research, Inc.

Country where clinical trial is conducted

South Africa, 

Outcome

Type Measure Description Time frame Safety issue
Primary Effectiveness of the ActivHeal Silicone PHMB foam adhesive and Non Adhesive foam dressing Effectiveness (performance) of the ActivHeal Silicone PHMB will be evaluated for efficacy success according to the following success criteria:
Reduction in signs and symptoms of infection from baseline as defined as
The change from the Investigator's opinion of infection being present to no longer being present, or
If the Investigator determines infection is still present there is improvement in severity of at least two.
No worsening of any signs/ symptoms of infection at 6 weeks or if infection resolved prior to 6 weeks, that no new evidence of infection occurred during the 6 week treatment follow up.
Immediately following initial assessment, dressing removal every 7 days follow up visits, for 6 weeks.
Secondary Safety of the ActivHeal Silicone PHMB foam adhesive and Non Adhesive foam dressing. Safety will evaluated as incidence of device related adverse events. Immediately following initial assessment, dressing removal every 7 days follow up visits, for 6 weeks.
Secondary Effectiveness of the ActivHeal Silicone PHMB foam adhesive and Non Adhesive foam dressing in terms of wound progression Wound progression, assessed as the change from baseline to end of follow up. Monitoring of tissue types %,decrease in devitalised tissue, size and depth of wound. Immediately following initial assessment, dressing removal every 7 days follow up visits, for 6 weeks.
Secondary Effectiveness of the ActivHeal Silicone PHMB foam adhesive and Non Adhesive foam dressing in terms of pain. Change in patient pain will be assessed using Visual Analogue Scale, VAS, from baseline to end of follow up. Pain will assessed by completion of a Visual Analogue Scale VAS (0= no pain to 10 = worst pain imaginable). Immediately following initial assessment, dressing removal every 7 days follow up visits, for 6 weeks.
Secondary Effectiveness of the ActivHeal Silicone PHMB foam adhesive and Non Adhesive foam dressing in terms of pain at dressing removal. Patient pain will be assessed on removal of the ActivHeal Silicone PHMB foam adhesive and Non Adhesive foam dressing ActivHeal Silicone PHMB foam adhesive and Non Adhesive foam dressing. Pain will assessed by completion of a Visual Analogue Scale, VAS(0= no pain to 10 = worst pain imaginable). Immediately following initial assessment, dressing removal every 7 days follow up visits, for 6 weeks.
Secondary Effectiveness of the ActivHeal Silicone PHMB foam adhesive and Non Adhesive foam dressing in terms of peri wound skin. Changes in the peri wound skin, prevents maceration. (Allows the uptake of exudate into the dressing.) Relative score will be used to score maceration of zero (no maceration), one (minimal maceration), two (moderate maceration), and three (excessive maceration and need to withdraw patient from study). Success will be determined that over the evaluation an increased score would represent peri wound deterioration. Immediately following initial assessment, dressing removal every 7 days follow up visits, for 6 weeks.
Secondary Effectiveness of the ActivHeal Silicone PHMB foam adhesive and Non Adhesive foam dressing in terms of dressing removal. Did the dressing cause trauma on removal to the wound (prevents formulation of granulation tissue growth into the pores of the dressing). Clinician and patient satisfaction with the device (ease of removal and no pain or trauma on removal) will be assessed using a likert type scale. (Very satisfied, Satisfied and not Satisfied). Immediately following initial assessment, dressing removal every 7 days follow up visits, for 6 weeks.
Secondary Effectiveness of the ActivHeal Silicone PHMB foam adhesive and Non Adhesive foam dressing in terms of repositioning. Can the dressing be repositioned and or lifted, securely placed back down. Clinician satisfaction with the device (conformability & ease of use) will be assessed using a Likert type scale. (Very satisfied, Satisfied and not Satisfied) Immediately following initial assessment, dressing removal every 7 days follow up visits, for 6 weeks.
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03649308 - Negative Pressure Wound Therapy Compared to Traditional Care After Skin Grafting N/A
Recruiting NCT03674749 - The Effects of Meditation and Hyperbaric Oxygen Therapy on Chronic Wounds N/A
Completed NCT06464250 - The Effect of Bundle Approach on Foot Care Behaviors and Diabetic Wound Healing in Patients N/A
Withdrawn NCT03909503 - A Case Series Evaluating a Collagen Wound Dressing to Treat Wounds N/A
Completed NCT05297721 - Nurses' Level of Knowledge on Skin Tears: A Cross-Sectional Study
Recruiting NCT03386175 - Efficiency of Negative Pression Therapy With Instillation in the Debridement of Wound
Active, not recruiting NCT04701632 - Prevalence and Variables Associated With Depression in Subjects With Chronic Wounds Using PHQ-9 as a Screening Tool
Completed NCT05618496 - Multi-centre, Open-label, First-in-man Study With Epipad Used in Adult Patients N/A
Not yet recruiting NCT03640871 - HEAL Study: Healing Results, Efficacy and Acceptability of a New Contact Layer N/A
Completed NCT02399722 - Combination of a Polymeric Membrane Dressing Plus Negative Pressure Wound Therapy Against Negative Pressure Wound Therapy Alone N/A
Completed NCT04507724 - The Use of Biochemical Analyzes to Monitor the Development of Wounds
Recruiting NCT05556954 - Diabetic Foot Ulcers Microbiome and Pathogen Identification
Completed NCT03938584 - The Effect of Vitamin C on Wound Healing In Mandibular Fracture Patients N/A
Terminated NCT03723603 - An Evaluation of a Collagen Dressing to Treat Chronic, Stalled Lower-extremity Wounds N/A
Completed NCT03754426 - A Prospective, Pilot Evaluation of Device Equivalence
Recruiting NCT02643680 - Clinical Study of Biocellulose Wound Dressing Containing Silk Sericin and PHMB for STSG Donor Sites Phase 2
Recruiting NCT01913132 - PICO Above Incisions After Vascular Surgery N/A
Recruiting NCT01347489 - Cronic Pressure Wounds and Relation With Gender N/A
Withdrawn NCT03723577 - An Evaluation of a Fibrillar Collagen Dressing to Treat Chronic, Stalled Lower-extremity Wounds N/A
Recruiting NCT06138964 - Comparing the Effect of siSPARC Microneedle Patch Versus siSPARC+siLR4A Microneedle Patch on Post-surgical Scars Phase 3